Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Shire plc : Miscellaneous


Posted on: 30 Jul 18

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

30 July 2018

Shire plc

("Shire" or the "Company")

Rule 2.9 Announcement

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 27 July 2018, being the last business day prior to the date of this announcement, it had 921,755,178 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange.  Shire holds 7,357,283 ordinary shares in treasury.  Accordingly, the total number of voting rights in Shire is 914,397,895.  The International Securities Identification Number ("ISIN") for Shire's ordinary shares is JE00B2QKY057.

Shire has an American Depositary Share ("ADS") programme for which Citibank, N.A. acts as depositary.  One ADS represents three ordinary shares of 5 pence each, with ISIN US82481R1068.  The ADSs trade on the NASDAQ Global Select Market.

Enquiries:

Shire plc

Christoph Brackmann (Investor Relations)          +41 41 288 4129
Sun Kim (Investor Relations)                             +1 617 588 8175
Katie Joyce (Media)                                          +1 781 482 2779

GlobeNewswire
globenewswire.com

Last updated on: 30/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.